Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ...Middle East

NEWTON, Mass., Sept. 1, 2022 /PRNewswire/ -- Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company approved the grant of stock options to purchase an aggregate of 40,800 shares of...

Read More Details
Finally We wish PressBee provided you with enough information of ( Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) )

Also on site :

• Men have hundreds more saved in ‘rainy day’ funds than women, research indicates
• Trump economic advisor confident in China trade deal conclusion on Monday
• Trump announces U.S.-China trade talks in London